Immunovant Inc. logo

Immunovant Inc.

IMVT | NASDAQ
Chart Builder DCF Calculator
$37.18
+$0.23 (+0.62%)
At close: Sep 21, 2026, 4:00 PM ET
$37.16
-$0.02 (-0.05%)
Pre-market: Sep 22, 2026, 8:31 AM ET

Market Data

Market Cap
$7.67B
Enterprise Value
$6.88B
Beta
0.81
Average Volume
1.57M
Shares Outstanding (Diluted)
205.55M
Shares Change YoY
20.29%
Institutional Ownership
60.63%
Exchange
NASDAQ
ISIN
US45258J1025

Price Performance

Price Change 1M
-15.5%
Price Change 3M
-1.2%
Price Change 6M
50.2%
Price Change YTD
43.5%
Price Change 1Y
138.5%
Price Change 3Y
82.3%
Price Change 5Y
329.8%
1M CAGR (ann.)
-6.9%
1Y CAGR (ann.)
141.4%
5Y CAGR (ann.)
33.7%
All-Time CAGR
19.9%

Valuation

PE Ratio
-13.18
Forward PE
N/A
PEG Ratio
-20.38
Forward PEG
22.85
PS Ratio
1,081.61
Forward PS
1,155.00
PB Ratio
10.44
P/FCF Ratio
-18.52
P/Adj. FCF Ratio
-16.49
P/OCF Ratio
-18.41
EV/Sales
969.17
EV/EBIT
-12.76
EV/EBITDA
-12.77
EV/FCF
-16.60
Earnings Yield
-7.6%
FCF Yield
-5.4%
Adj. FCF Yield
-6.1%

Financial Health

Net Cash
$797.8M
Total Debt
$0
Cash & Short-Term Investments
$797.8M
Total Assets
$852.49M
Current Ratio
7.27
Quick Ratio
7.27
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
0.00
Altman Z-Score
35.16
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
97.1%
Operating Profit Margin
-7877.5%
EBITDA Margin
-7590.1%
Net Profit Margin
-7585.9%
FCF Margin
-5839.5%
Adj. FCF Margin
-6558.1%
SBC / Revenue
718.6%
SBC Impact (per share)
-12.3%

Returns

Return on Assets
-63.1%
Return on Equity
-69.6%
Return on Invested Capital
-75.9%
Return on Capital Employed
-76.0%
Return on Tangible Assets
-63.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
150.0%
Revenue CAGR 5Y
100.0%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-17.6%
EPS CAGR 5Y
-16.4%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-23.8%
FCF CAGR 5Y
-27.7%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
23
EPS Growth Next 3Y
11.2%
Revenue Growth Next 3Y
284.5%
Earnings Date
Nov 8, 2026
EPS Estimate (next Q)
-$0.73
EPS Growth Est (next Q)
0.0%
Revenue Est (next Q)
$7.1M
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$40
Price Target Upside
7.6%

Cash Flow

Operating Cash Flow
$-414.3M
Free Cash Flow
$-414.31M
Adj. Free Cash Flow
$-465.3M
FCF Per Share
-$2.02
OCF Per Share
-$2.02
OCF/S Ratio
-5839.4%

Income Statement

Revenue
$7.1M
Gross Profit
$6.89M
Operating Income
$-558.91M
EBITDA
$-538.52M
Net Income
$-538.22M
EPS (Diluted)
-$2.82
Revenue / Employee
$22.52K
Profit / Employee
$-1.71M
Employees
315

© 2026 bestshares.com. All rights reserved.